Cosmetics and the FDA.
作者信息
Eiermann H J
出版信息
Arch Dermatol. 1976 Jul;112(7):1023-4. doi: 10.1001/archderm.112.7.1023.
PMID:938066
Abstract
摘要
相似文献
1
Cosmetics and the FDA.
Arch Dermatol. 1976 Jul;112(7):1023-4. doi: 10.1001/archderm.112.7.1023.
2
Cosmetics: a view from the bridge.
J Am Med Womens Assoc (1972). 1974 Jul;29(7):310-4.
3
Cosmetic legislation: benefit-risk.
J Am Med Womens Assoc (1972). 1974 Jul;29(7):306-9.
4
Safe Cosmetics Act aims to lessen cancer risk.《安全化妆品法案》旨在降低癌症风险。
J Natl Cancer Inst. 2006 Oct 18;98(20):1441-2. doi: 10.1093/jnci/djj446.
5
Cosmetic legislation: technical consideration.
J Am Med Womens Assoc (1972). 1974 Jul;29(7):318-20, 322-3.
6
Cosmetology, cosmetics, cosmeceuticals: definitions and regulations.美容学、化妆品、药妆品：定义与法规
Clin Dermatol. 2001 Jul-Aug;19(4):371-4. doi: 10.1016/s0738-081x(01)00195-x.
7
Regulatory issues concerning AETT and 6-MC.关于氨基乙磺酸和6-甲基巯基嘌呤的监管问题。
Contact Dermatitis. 1980 Jan;6(2):120-2. doi: 10.1111/j.1600-0536.1980.tb03918.x.
8
FDA law enforcement: critical to product safety.美国食品药品监督管理局的执法工作：对产品安全至关重要。
FDA Consum. 2006 Jan-Feb;40(1):21-7.
9
The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.化妆品/药品困境：美国食品药品监督管理局对α-羟基酸的监管
Food Drug Law J. 1997;52(4):357-75.
10
American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
Food Drug Law J. 2008;63(1):257-74.
Zotero 插件